Home » Topics » Regulatory

Regulatory
RSS

New beclomethasone formulation cleared for marketing

July 5, 1996

New Iomeron formulation introduced in Japan

July 5, 1996

Low-dose lovastatin + niacin shows good efficacy and safety in patient study

July 5, 1996

Prosorba trial initiated in arthritis sufferers

July 5, 1996

Vistide approved in U.S.

July 5, 1996

Phase III trials of Alferon N Injection initiated in HIV-positive patients

July 5, 1996

Nadolol/isosorbide monohydrate combination prevents rebleeding

June 28, 1996

Gabitril approved in France as add-on therapy

June 28, 1996

Depakote receives FDA approval for new indication

June 28, 1996

Virulizin undergoes phase I/II in pancreatic cancer

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.